Last Update

2016-08-31T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Chrystal Menard?

Ms. Chrystal N. Menard

Chief Legal Officer

Cerus Corporation

Direct Phone: (925) ***-****       

Email: c***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Cerus Corporation

2550 Stanwell Drive Ste 300

Concord, California 94520

United States

Company Description

Cerus Corporation is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses ... more

Find other employees at this company (299)

Background Information

Employment History

Senior Corporate Counsel

ZYNGA INC

Education

Bachelor of Science

finance and accounting

University of Colorado , Boulder

Juris Doctorate

University of Chicago

Web References (25 Total References)


Cerus - Investors - Press Releases

www.cerus.com [cached]

10/25/2012 Cerus Appoints Chrystal Menard as Chief Legal Officer 10/16/2012 Cerus to Release Third Quarter Results on October 30, 2012 09/11/2012 Cerus to Partner with American Red Cross and Blood Systems Incorporated to Commercialize INTERCEPT Plasma for Thrombotic Thrombocytopenic Purpura (TTP) Orphan Indication 08/30/2012 Cerus to Present at the Baird Healthcare Conference on September 6, 2012 08/29/2012 Cerus to Present at the Stifel Nicolaus Weisel Healthcare Conference on September 5, 2012 08/08/2012 Cerus to Present at the Wedbush 2012 Life Sciences Management Access Conference on August 14 08/07/2012 Cerus Announces First INTERCEPT Blood System Customer in Turkey 08/02/2012 Cerus Corporation Reports Second Quarter 2012 Results 07/19/2012 Cerus to Release Second Quarter 2012 Results on August 2, 2012 05/01/2012 Cerus Corporation Reports First Quarter 2012 Results 04/30/2012 Cerus, the University Hospitals of Geneva, and the Transfusion Service of the Swiss Red Cross Intend to Collaborate on Whole Blood Pathogen Inactivation for Africa 04/24/2012 Cerus and New York Blood Center to Collaborate on Development of Novel Red Blood Cell Biologic Product with Improved Uniformity 04/18/2012 Cerus Announces First INTERCEPT Platelet System Customer in Austria 04/12/2012 Cerus to Release First Quarter 2012 Results on May 1, 2012 04/03/2012 Cerus Announces New Supply Agreement with Largest Blood Service in Saudi Arabia 03/21/2012 Cerus Submits Investigational Device Exemption (IDE) Supplement to FDA for Phase III INTERCEPT Red Blood Cell Study 02/29/2012 Cerus to Present at the Cowen and Company 32nd Annual Healthcare Conference on March 7, 2012 02/28/2012 Cerus Corporation Reports Fourth Quarter and Year-End 2011 Results 02/06/2012 Cerus to Present at the 14th Annual BIO CEO & Investor Conference on February 13, 2012 02/02/2012 Cerus to Release Fourth Quarter and Year-End 2011 Results on February 28, 2012


Cerus - Management Team

www.cerus.com [cached]

- Chrystal Menard - Chief Legal Officer

...
Chrystal Menard Chief Legal Officer
...
Ms. Menard was appointed Chief Legal Officer in 2012. Prior to joining Cerus, Ms. Menard served as senior corporate counsel at Zynga, Inc. From 2000-2011, she was a partner at Cooley LLP, where she had practiced corporate and securities law. Ms. Menard received her Juris Doctorate from the University of Chicago and her Bachelor of Science in finance and accounting from the University of Colorado, Boulder.


Cerus - Management Team

www.cerus.com [cached]

William 'Obi' M. Greenman | Richard J. Benjamin MBChB, PhD, FRCPath | Laurence M. Corash, M.D. | Kevin D. Green | Caspar Hogeboom | Suzanne Margerum | Chrystal Menard | Carol Moore | Nina Mufti | Lori L. Roll | Adonis Stassinopoulos | Kenneth Trader

...
- Chrystal Menard - Chief Legal Officer
...
Chrystal Menard Chief Legal Officer
...
Ms. Menard was appointed Chief Legal Officer in 2012. Prior to joining Cerus, Ms. Menard served as senior corporate counsel at Zynga, Inc. From 2000-2011, she was a partner at Cooley LLP, where she had practiced corporate and securities law. Ms. Menard received her Juris Doctorate from the University of Chicago and her Bachelor of Science in finance and accounting from the University of Colorado, Boulder.


Cerus - Management Team

investor.cerus.com [cached]

- Chrystal Menard - Chief Legal Officer

...
Chrystal Menard Chief Legal Officer
Years with Cerus : Joined December 2012
Ms. Menard was appointed Chief Legal Officer in December 2012. Prior to joining Cerus, Ms. Menard served as senior corporate counsel at Zynga, Inc. From 2000-2011, she was a partner at Cooley LLP, where she had practiced corporate and securities law. Ms. Menard received her Juris Doctorate from the University of Chicago and her Bachelor of Science in finance and accounting from the University of Colorado, Boulder.


Cerus - Investors - Press Releases

www.cerus.com [cached]

10/25/2012 Cerus Appoints Chrystal Menard as Chief Legal Officer 10/16/2012 Cerus to Release Third Quarter Results on October 30, 2012 09/11/2012 Cerus to Partner with American Red Cross and Blood Systems Incorporated to Commercialize INTERCEPT Plasma for Thrombotic Thrombocytopenic Purpura (TTP) Orphan Indication 08/30/2012 Cerus to Present at the Baird Healthcare Conference on September 6, 2012 08/29/2012 Cerus to Present at the Stifel Nicolaus Weisel Healthcare Conference on September 5, 2012 08/08/2012 Cerus to Present at the Wedbush 2012 Life Sciences Management Access Conference on August 14 08/07/2012 Cerus Announces First INTERCEPT Blood System Customer in Turkey 08/02/2012 Cerus Corporation Reports Second Quarter 2012 Results 07/19/2012 Cerus to Release Second Quarter 2012 Results on August 2, 2012 05/01/2012 Cerus Corporation Reports First Quarter 2012 Results 04/30/2012 Cerus, the University Hospitals of Geneva, and the Transfusion Service of the Swiss Red Cross Intend to Collaborate on Whole Blood Pathogen Inactivation for Africa 04/24/2012 Cerus and New York Blood Center to Collaborate on Development of Novel Red Blood Cell Biologic Product with Improved Uniformity 04/18/2012 Cerus Announces First INTERCEPT Platelet System Customer in Austria 04/12/2012 Cerus to Release First Quarter 2012 Results on May 1, 2012 04/03/2012 Cerus Announces New Supply Agreement with Largest Blood Service in Saudi Arabia 03/21/2012 Cerus Submits Investigational Device Exemption (IDE) Supplement to FDA for Phase III INTERCEPT Red Blood Cell Study 02/29/2012 Cerus to Present at the Cowen and Company 32nd Annual Healthcare Conference on March 7, 2012 02/28/2012 Cerus Corporation Reports Fourth Quarter and Year-End 2011 Results 02/06/2012 Cerus to Present at the 14th Annual BIO CEO & Investor Conference on February 13, 2012 02/02/2012 Cerus to Release Fourth Quarter and Year-End 2011 Results on February 28, 2012

Similar Profiles

Other People with this Name

Other people with the name Menard

Yan Ménard
Groupe ABS

Melissa Menard
Achieve Wellness Spa

Jeanne Menard
Parade Properties

Giles Menard
Lafayette Airport Commission

Mary Menard
LightingDesigner

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory